1-3 of 3
Isaac Yi Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling

Yong-June Kim, Hyung-Yoon Yoon, Seon-Kyu Kim, Young-Won Kim, Eun-Jung Kim, Isaac Yi Kim, Wun-Jae Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4523–4530.
https://doi.org/10.1158/1078-0432.CCR-10-2817
Published: 05 July 2011
View article titled, <em>EFEMP1</em> as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling
Open the PDF for <em>EFEMP1</em> as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling in another window
Journal Articles

Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells

Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, Byung Chul Kim, Heung Tae Kim, Fredrick S. Leach, W. Marston Linehan, Ronald A. Morton, Seong Jin Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 6046–6051.
Published: 15 December 2003
View article titled, Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells
Open the PDF for Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells in another window
Journal Articles

Decreased Expression of Transforming Growth Factor β Receptor Type I Is Associated with Poor Prognosis in Bladder Transitional Cell Carcinoma Patients

Hideo Tokunaga, Dong-Hyeon Lee, Isaac Yi Kim, Thomas M. Wheeler, Seth P. Lerner
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2520–2525.
Published: 01 September 1999
View article titled, Decreased Expression of Transforming Growth Factor β Receptor Type I Is Associated with Poor Prognosis in Bladder Transitional Cell Carcinoma Patients
Open the PDF for Decreased Expression of Transforming Growth Factor β Receptor Type I Is Associated with Poor Prognosis in Bladder Transitional Cell Carcinoma Patients in another window